MedPath

Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial

Not Applicable
Completed
Conditions
Alcohol-Related Disorders
Liver Diseases
Interventions
Behavioral: Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool
Registration Number
NCT04473482
Lead Sponsor
University of Michigan
Brief Summary

The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ways to increase participants' knowledge about different treatment options as well as increase likelihood of seeking and participating in alcohol use disorder treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Enrolled at University of Michigan general hepatology clinics or inpatient wards
  • Documented diagnosis of alcohol-associated cirrhosis or alcoholic hepatitis or alcohol-related liver disease of any stage
  • Drinking of any amount of alcohol within the 6 months prior to recruitment
  • No alcohol use treatment within the past 1 month
  • Access to a phone for purposes of follow-up
Read More
Exclusion Criteria
  • Active alcohol use treatment
  • Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation.
  • Is enrolled in the multidisciplinary alcohol-related liver disease clinic at Michigan Medicine
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MAIN-ART Behavior ToolMichigan Alcohol Improvement Network-Alcohol Reduction and Treatment toolThe Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Tool (MAIN-ART) behavioral intervention is an online web application with two modules: misconception correction and tailored, preference-sensitive alcohol use disorder (AUD) treatment matching.
Primary Outcome Measures
NameTimeMethod
Feasibility of MAIN-ART Tool as Measured by Recruitment RatesUp to 6 months

Feasibility of administration of the MAIN-ART tool will be determined by recruitment rates and retention rates (as measured at 6 months after recruitment). Study recruitment started on 23 September, 2020 and concluded on 10 January 2022. The results reflect the number and percent of those patients who were approached, were determined to be eligible, and were consented.

Feasibility of MAIN-ART Tool as Measured by Retention RatesUp to 6 months

Feasibility of administration of the MAIN-ART tool will be determined by recruitment rates and retention rates (as measured at 6 months after recruitment). Retention rate is shown by the number of participants who continued in the study for 6 months, and the percentage that it represents compared to those who began it but did not follow through to the end of the study (6 months).

Acceptability of the MAIN-ART Tool as Measured by Post-intervention SurveysUp to 1 hour

On the day the participants engage with the MAIN-ART tool, acceptability will be determined by patient-level surveys. The System usability Survey (SUS) consists of 10 questions ranging from 1 (strongly disagree) to 5 (strongly agree). A scoring algorithm which produces a range from 0 to 100 was used. Current literature suggests that a score above 68 for mean SUS is considered "above average." By "intervention," this measure means interaction with the MAIN-ART tool, which occurs only at the participant's initial visit.

Secondary Outcome Measures
NameTimeMethod
Alcohol Use Frequency as Measured by the Alcohol Timeline Follow-back (TLFB) InterviewBaseline and 6 months

Alcohol use will be defined according to World Health Organization (WHO) risk drinking level. WHO drinking risk levels were derived from patient reports of the number of standard drinks (defined as 0.6 ounces of absolute alcohol) consumed, which were converted to grams of pure alcohol (0.6 ounces = 14 grams). Ranging from abstinence (0 grams) to very high risk (101+ males / 61+ females grams).

Alcohol Treatment Engagement as Measured by Number of Participants Who Engaged in Any Alcohol Cessation or Reduction Visit as Measured by Self-report.Up to 6 months

Alcohol treatment engagement will be defined as at least one visit with formal, external assistance in alcohol cessation or reduction including inpatient rehabilitation services, out patient alcohol cessation programs, engagement in therapy of any kind tailored for alcohol cessation, and engagement in any group therapy or support groups for alcohol cessation including alcoholics anonymous, 12 step facilitation and etc.

Trial Locations

Locations (1)

The University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath